Vyome Holdings
Cambridge, Massachusetts, United States · Biotechnology, Health Care, Medical
Vyome is a clinical-stage healthcare holding company focusing on transformative therapies for patients with immuno-inflammatory conditions. They are building a premier platform spanning the US-India innovation corridor. Vyome aims to leverage its clinical-stage assets to create shareholder value in a cost-efficient manner.
Key facts
- Headquarters
- Cambridge, Massachusetts, United States
- Employees
- 19
- Industries
- Biotechnology, Health Care, Medical
- Status
- Public (HIND)
- Website
- vyometx.com
- Company page
Recent activity at Vyome Holdings
- : Vyome Appoints Jerry Leonard as Chief Financial Officer
- : SEC 8-K (2.02): On August 25, 2026, Vyome Holdings, Inc. announced its financial results for the second fiscal quarter ending June 30, 2026. The press release details the company's performance metrics, which are crucial for investors and stakeholders to assess financial health and operational success. Such announcements typically influence stock prices and investor sentiment. This event is critical for understanding the company's ongoing financial condition and operational performance as it moves through its fiscal year.
- : SEC 8-K (7.01): Vyome Holdings, Inc. has filed a Form 8-K to disclose that company representatives will be presenting at investor conferences. This disclosure includes materials attached as Exhibit 99.1, which contains pertinent information about the company's operations and performance. The relevant date of the events described in the filing is February 13, 2026, which is the same day as this report. This presentation aims to provide investors with updated information regarding the company's activities and strategies, ensuring compliance with Regulation FD.
- : Vyome Holdings Enters Letter of Intent for Acquisition of Convertible Note
- : SEC 8-K (1.01): On December 17, 2025, Vyome Holdings, Inc. entered into a binding letter of intent with LiveChain, Inc. (LICH) and Remus Capital Series B II, L.P. regarding a proposed transaction where LICH, an indirect subsidiary of Vyome, will acquire a senior secured convertible note from Sociometric Solutions, Inc. d/b/a Humanyze, held by Remus. As part of this transaction, LICH will issue shares to Remus representing 25% of the fully diluted common stock of LICH. The agreement outlines the formation of a new subsidiary by LICH, named Newco Sub, which will finalize the Note Purchase and Exchange Agreement. This strategic move aims to enhance LICH’s financial position by acquiring significant assets from Humanyze.
- : Vyome Holdings Appoints Dr. Richard Fahrner as Chief Technology Officer
Leadership
- Jerry Leonard, Chief Financial Officer
- Manoj Sharma, Senior Associate Scientist
- Akshay Kumar, Analytical Scientist
- Nitin Gaur
- Srivani Mukkamala, Program Management
- Anubhuti Jain, Scientist II
- Pardeep Kumar, Sr. Manager
- Tamara Agajanov McNally, Vice President
- Richard Fahrner, Chief Technology Officer
Verified email and direct lines for Vyome Holdings’s decision-makers are on Fundz. See plans
Vyome Holdings in the news
Companies similar to Vyome Holdings
- Citius Oncology · Biotechnology, Health Care, Medical, Therapeutics
- SymPhysis Medical · Biotechnology, Health Care, Medical, Therapeutics
- Medical Technology Enterprise Consortium (MTEC) · Biotechnology, Health Care, Medical, Therapeutics
- Aerska · Biotechnology, Health Care, Medical, Therapeutics
- Galecto · Biotechnology, Health Care, Medical, Therapeutics
About Vyome Holdings: questions and answers
What does Vyome Holdings do?
Vyome is a clinical-stage healthcare holding company focusing on transformative therapies for patients with immuno-inflammatory conditions. They are building a premier platform spanning the US-India innovation corridor. Vyome aims to leverage its clinical-stage assets to create shareholder value in a cost-efficient manner.
Where is Vyome Holdings headquartered?
Vyome Holdings is headquartered in Cambridge, Massachusetts, United States.
How many employees does Vyome Holdings have?
Vyome Holdings has about 19 employees.
Who leads Vyome Holdings?
Tamara Agajanov McNally is a Vice President at Vyome Holdings.
What is the latest news on Vyome Holdings?
On Sep 14, 2026, Vyome Appoints Jerry Leonard as Chief Financial Officer
Is Vyome Holdings a public company?
Yes. Vyome Holdings is publicly traded under the ticker HIND.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy